Severity in the ICD-11 personality disorder model: Evaluation in a Spanish mixed sample
Por:
Gutiérrez F., Aluja A., Rodríguez C., Gárriz M., Peri J.M., Gallart S., Calvo N., Ferrer M., Gutiérrez-Zotes A., Soler J., Pascual J.C.
Publicada:
1 ene 2023
Ahead of Print:
9 ene 2023
Resumen:
Severity is the main component of the ICD-11 personality disorder (PD) classification, but pertinent instruments have only recently been developed. We analyzed the psychometric properties of the ICD-11 Personality Disorder Severity scale (PDS-ICD-11) in a mixed sample of 726 community and clinical subjects. We also examined how the different components of the ICD-11 PD system —five trait domains, the borderline pattern specifier, and severity, all of them measured through self-reports— are interconnected and operate together. PDS-ICD-11 properties were adequate and similar to those of the original instrument. However, regressions and factor analyses showed a considerable overlap of severity with the five personality domains and the borderline specifier (72.6%). Bifactor modeling resulted in a general factor of PD (g-PD) that was not equivalent to severity nor improved criterion validity. The whole ICD-11 PD system, i.e., five personality domains, borderline, and severity, explained an average of 43.6% of variance of external measures of well-being, disability, and clinical problems, with severity contributing 4.8%. Suggestions to further improve the ICD-11 PD taxonomy include remodeling the present definition of severity to give more weight to the real-life consequences of traits. Copyright © 2023 Gutiérrez, Aluja, Rodríguez, Gárriz, Peri, Gallart, Calvo, Ferrer, Gutiérrez-Zotes, Soler and Pascual.
Filiaciones:
Gutiérrez F.:
Institute of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Spain
Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
Aluja A.:
Lleida Institute for Biomedical Research Dr. Pifarré Foundation, Lleida, Spain
Department of Psychology, University of Lleida, Lleida, Spain
Rodríguez C.:
Institute of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Spain
Gárriz M.:
Neuropsychiatry and Drug Addiction Institute, Parc de Salut Mar, Barcelona, Spain
Peri J.M.:
Institute of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Spain
Gallart S.:
Department of Psychiatry, Mental Health, and Addiction, GSS–Hospital Santa Maria, Lleida, Spain
Calvo N.:
Department of Psychiatry, Vall d’Hebron University Hospital, Barcelona, Spain
Network Centre for Biomedical Research in Mental Health (CIBERSAM), Barcelona, Spain
Psychiatry and Legal Medicine Department, Autonomous University of Barcelona, Barcelona, Spain
Ferrer M.:
Department of Psychiatry, Vall d’Hebron University Hospital, Barcelona, Spain
Network Centre for Biomedical Research in Mental Health (CIBERSAM), Barcelona, Spain
Psychiatry and Legal Medicine Department, Autonomous University of Barcelona, Barcelona, Spain
Gutiérrez-Zotes A.:
Network Centre for Biomedical Research in Mental Health (CIBERSAM), Barcelona, Spain
Pere Virgili Health Research Institute (IISPV), CERCA, Reus, Spain
Pere Mata Psychiatric University Hospital, Reus, Spain
Soler J.:
Psychiatry and Legal Medicine Department, Autonomous University of Barcelona, Barcelona, Spain
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Pascual J.C.:
Psychiatry and Legal Medicine Department, Autonomous University of Barcelona, Barcelona, Spain
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
gold, Green Published, All Open Access, Gold, Green
|